{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:37:33Z","timestamp":1760297853197},"reference-count":42,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2007,8,27]],"date-time":"2007-08-27T00:00:00Z","timestamp":1188172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[2007,12,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The decision to introduce liquid\u2010based cytology (LBC) and HPV as screening tests involves criteria based on resource consumption. We used cross\u2010sectional data at recruitment from the NTCC trial [ISRCTN81678807] on 28,000 women aged 35\u201360, randomised to receive a conventional Pap test or LBC plus HPV. We computed the resources employed to detect a CIN2+ with different screening strategies. In order to result in the same overall cost per CIN2+ detected as screening by conventional cytology, the unit cost of LBC used alone should be less than that of a conventional Pap while its unit cost may be up to 20% higher if HPV\u2010triage for Atypical Squamous Cells of Undetermined Significance is applied together. With the same criterion the unit cost of HPV used alone may be about 20% higher than that of a Pap\u2010test using a 1 pg\/ml cut\u2010off and over 40% higher using a 10 pg\/ml cut\u2010off. If HPV testing is applied with cytology\u2010triage, a single HPV test may cost 20\u201330% more than a conventional Pap to result in the same overall cost per CIN2+ detected. \u00a9 2007 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ijc.23055","type":"journal-article","created":{"date-parts":[[2007,8,27]],"date-time":"2007-08-27T17:16:32Z","timestamp":1188234992000},"page":"2729-2734","source":"Crossref","is-referenced-by-count":9,"title":["The impact of new technologies in cervical cancer screening: Results of the recruitment phase of a large randomised controlled trial from a public health perspective"],"prefix":"10.1002","volume":"121","author":[{"given":"Paolo","family":"Giorgi\u2010Rossi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nereo","family":"Segnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Zappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Naldoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Zorzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Confortini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Merito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Cuzick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guglielmo","family":"Ronco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,8,27]]},"reference":[{"key":"e_1_2_9_2_2","volume-title":"Cervix Cancer Screening. IARC Handbooks of Cancer Prevention No10","author":"IARC Working Group on the Evaluation of Cancer Preventive Strategies","year":"2005"},{"key":"e_1_2_9_3_2","first-page":"6027","article-title":"A prospective study showing long\u2010term infection with human papillomavirus 16 before the development of cervical carcinoma in situ","volume":"60","author":"Ylitalo N","year":"2000","journal-title":"Cancer Res"},{"key":"e_1_2_9_4_2","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2000.1491"},{"key":"e_1_2_9_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601355"},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)67961-0"},{"key":"e_1_2_9_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000210529.70226.0a"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/dc.20283"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000120143.50098.c7"},{"key":"e_1_2_9_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji162"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38698.458866.7C"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600073"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(02)02195-6"},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-004-0254-1"},{"key":"e_1_2_9_15_2","unstructured":"MossSM GrayA LegoodR HenstockE. First report to the Department of Health on evaluation of LBC (December 2002)http:\/\/www.cancerscreening.nhs.uk\/cervical\/lbc\u2010pilot\u2010ev.(accessed March 29 2006)."},{"key":"e_1_2_9_16_2","unstructured":"Cervical Screening Wales. Liquid based cytology\u2014pilot project: project report. Cardiff: Velindre NHS Trust 2003."},{"key":"e_1_2_9_17_2","unstructured":"Scottish Cervical Screening Programme. Steering Group report on the feasibility of introducing liquid based cytologyhttp:\/\/www.show.scot.nhs.uk\/publicationsindex.htm(accessed March 22 2006)."},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.16.2120"},{"key":"e_1_2_9_19_2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/jnci\/93.4.293","article-title":"ALTS Study group. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial","volume":"93","author":"Solomon D","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.17.1605"},{"key":"e_1_2_9_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14955-0"},{"key":"e_1_2_9_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690730"},{"key":"e_1_2_9_23_2","doi-asserted-by":"publisher","DOI":"10.3310\/hta3140"},{"key":"e_1_2_9_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91086-7"},{"key":"e_1_2_9_25_2","first-page":"945","article-title":"Human papillomavirus testing for primary screening of cervical cancer precursors","volume":"9","author":"Ratnam S","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"e_1_2_9_26_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.14.1749"},{"key":"e_1_2_9_27_2","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2001.1845"},{"key":"e_1_2_9_28_2","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/jnci\/92.10.818","article-title":"Human papillomavirus DNA testing for cervical cancer screening in low\u2010resource settings","volume":"92","author":"Kuhn L","journal-title":"J Natl Cancer Inst 2000"},{"key":"e_1_2_9_29_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.1.87"},{"key":"e_1_2_9_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh037"},{"key":"e_1_2_9_31_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1024806707399"},{"key":"e_1_2_9_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600918"},{"key":"e_1_2_9_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20000815)89:4<826::AID-CNCR15>3.0.CO;2-5"},{"key":"e_1_2_9_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0215(20001120)89:6<529::AID-IJC11>3.0.CO;2-G"},{"key":"e_1_2_9_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj209"},{"key":"e_1_2_9_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(06)70731-8"},{"key":"e_1_2_9_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8510(01)00142-7"},{"key":"e_1_2_9_38_2","doi-asserted-by":"publisher","DOI":"10.1177\/030089169808400603"},{"key":"e_1_2_9_39_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.6.781"},{"key":"e_1_2_9_40_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa044278"},{"key":"e_1_2_9_41_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.18.2382"},{"key":"e_1_2_9_42_2","doi-asserted-by":"publisher","DOI":"10.3310\/hta8200"},{"key":"e_1_2_9_43_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.18.2372"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.23055","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.23055","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T09:43:53Z","timestamp":1696844633000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.23055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,27]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12,15]]}},"alternative-id":["10.1002\/ijc.23055"],"URL":"https:\/\/doi.org\/10.1002\/ijc.23055","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,27]]}}}